← All trials
NCT01127204
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2011
- Primary completion
- Apr 1, 2015
- Completion date
- Apr 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 161
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- French National Agency for Research on AIDS and Viral HepatitisLead sponsor
- Center for Infectious Desease Control - Kigali, RwandaOverall official - principal investigator
- Institut National de la Santé Et de la Recherche Médicale, FranceCollaborator
- University of BordeauxCollaborator
- Free University of BrusselsCollaborator
- European and Developing Countries Clinical Trials Partnership (EDCTP)Collaborator
- Public Research Centre Health, LuxembourgCollaborator
- University of OuagadougouCollaborator
- Government of LuxembourgCollaborator
- Government of RwandaCollaborator
- University of ParisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.